Skip to content
Screener

Common Stock at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$1.19M+1.0%
UnitedHealth Group logo
UnitedHealth GroupUNH
3B0.0%
Conduent Incorporated logo
Conduent IncorporatedCNDT
155.5M+7,676%
Corvel logo
CorvelCRVL
$5K0.0%
Phreesia logo
PhreesiaPHR
$632K+3.9%
IQVIA logo
IQVIAIQV
400M0.0%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValueOutstanding.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemJune 30, 2026December 31, 2025
Shareholders’ deficit:
Shareholder interests
Preferred stock, $0.0001 par value — 10,000,000 shares authorized; no shares issued
Common stock, $0.0001 par value — 1,500,000,000 shares authorized; 17,814,829 and 17,295,582 issued; 16,935,754 and 16,552,723 shares outstanding as of June 30, 2026 and December 31, 2025, respectively22
Additional paid-in capital2,410,8312,398,423
Accumulated deficit(2,562,206)(2,429,420)
Accumulated other comprehensive loss(955)(4,172)
Treasury stock - 879,075 and 742,859 shares as of June 30, 2026 and December 31, 2025, respectively(142,236)(138,733)

Item 1. Financial Statements

FAQ

What is Claritev Corporation's common stock?
Claritev Corporation (CTEV) reported common stock of $2K in Q2 2026.
How has Claritev Corporation's common stock changed year-over-year?
Claritev Corporation's common stock decreased by 0.0% year-over-year, from $2K to $2K.
What is the long-term trend for Claritev Corporation's common stock?
Over 5 years (2020 to 2025), Claritev Corporation's common stock has grown at a -50.3% compound annual growth rate (CAGR), from $66K to $2K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Claritev Corporation's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude